Nektar Therapeutics Comprehensive Income
Nektar Therapeutics (NKTR) reported Comprehensive Income of -$41.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-14
- Nektar Therapeutics comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$41.34M.
- Nektar Therapeutics comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$45.95M.
- Nektar Therapeutics comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$36.12M, a 618.42% decline year-over-year.
- Nektar Therapeutics comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$35.45M.
- Nektar Therapeutics comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$164.12M.
- Nektar Therapeutics comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$118.98M.
- Nektar Therapeutics comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$269.07M.
- Nektar Therapeutics comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$370.95M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$41.34M 10-Q · filed 2026-08-14 | -$87.30M 10-Q · filed 2026-08-14 | -$123.42M derived: sum of 3 quarters · filed 2026-08-14 | -$158.87M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$45.95M 10-Q · filed 2026-08-14 | -$82.07M derived: sum of 2 quarters · filed 2026-08-14 | -$117.53M derived: sum of 3 quarters · filed 2026-08-14 | -$159.17M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$36.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$71.57M derived: sum of 2 quarters · filed 2026-03-13 | -$113.22M derived: sum of 3 quarters · filed 2026-08-14 | -$164.12M 10-K · filed 2026-03-13 |
| 2025-09-30 | -$35.45M 10-Q · filed 2025-11-07 | -$77.10M derived: sum of 2 quarters · filed 2026-08-14 | -$128.00M 10-Q · filed 2025-11-07 | -$121.03M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$41.65M 10-Q · filed 2026-08-14 | -$92.55M 10-Q · filed 2026-08-14 | -$85.58M derived: sum of 3 quarters · filed 2026-08-14 | -$121.79M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$50.90M 10-Q · filed 2026-08-14 | -$43.94M derived: sum of 2 quarters · filed 2026-08-14 | -$80.14M derived: sum of 3 quarters · filed 2026-08-14 | -$132.60M derived: sum of 4 quarters · filed 2026-08-14 |
| 2024-12-31 | $6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$29.24M derived: sum of 2 quarters · filed 2026-03-13 | -$81.69M derived: sum of 3 quarters · filed 2026-03-13 | -$118.98M 10-K · filed 2026-03-13 |
| 2024-09-30 | -$36.21M 10-Q · filed 2025-11-07 | -$88.66M derived: sum of 2 quarters · filed 2025-11-07 | -$125.95M 10-Q · filed 2025-11-07 | -$161.59M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$52.45M 10-Q · filed 2025-11-07 | -$89.74M 10-Q · filed 2025-08-08 | -$125.39M derived: sum of 3 quarters · filed 2025-11-07 | -$171.13M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-03-31 | -$37.28M 10-Q · filed 2025-11-07 | -$72.93M derived: sum of 2 quarters · filed 2025-11-07 | -$118.67M derived: sum of 3 quarters · filed 2025-11-07 | -$170.56M derived: sum of 4 quarters · filed 2025-11-07 |
| 2023-12-31 | -$35.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$81.39M derived: sum of 2 quarters · filed 2025-03-14 | -$133.28M derived: sum of 3 quarters · filed 2025-03-14 | -$269.07M 10-K · filed 2025-03-14 |
| 2023-09-30 | -$45.74M 10-Q · filed 2024-11-08 | -$97.63M derived: sum of 2 quarters · filed 2024-11-08 | -$233.42M 10-Q · filed 2024-11-08 | -$291.85M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$51.89M 10-Q · filed 2024-11-08 | -$187.68M 10-Q · filed 2024-08-09 | -$246.11M derived: sum of 3 quarters · filed 2024-11-08 | -$305.14M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-03-31 | -$135.79M 10-Q · filed 2024-11-08 | -$194.22M derived: sum of 2 quarters · filed 2024-11-08 | -$253.25M derived: sum of 3 quarters · filed 2024-11-08 | -$413.97M derived: sum of 4 quarters · filed 2024-11-08 |
| 2022-12-31 | -$58.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$117.45M derived: sum of 2 quarters · filed 2024-03-05 | -$278.18M derived: sum of 3 quarters · filed 2024-03-05 | -$370.95M 10-K · filed 2024-03-05 |
| 2022-09-30 | -$59.03M 10-Q · filed 2023-11-08 | -$219.75M derived: sum of 2 quarters · filed 2023-11-08 | -$312.52M 10-Q · filed 2023-11-08 | -$458.76M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | -$160.73M 10-Q · filed 2023-11-08 | -$253.50M 10-Q · filed 2023-08-09 | -$399.73M derived: sum of 3 quarters · filed 2024-03-05 | -$529.60M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | -$92.77M 10-Q · filed 2023-11-08 | -$239.01M derived: sum of 2 quarters · filed 2024-03-05 | -$368.88M derived: sum of 3 quarters · filed 2024-03-05 | -$494.67M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | -$146.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$276.11M derived: sum of 2 quarters · filed 2024-03-05 | -$401.91M derived: sum of 3 quarters · filed 2024-03-05 | -$525.70M 10-K · filed 2024-03-05 |
| 2021-09-30 | -$129.87M 10-Q · filed 2022-11-04 | -$255.67M derived: sum of 2 quarters · filed 2022-11-04 | -$379.46M 10-Q · filed 2022-11-04 | -$497.88M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$125.80M 10-Q · filed 2022-11-04 | -$249.59M 10-Q · filed 2022-08-05 | -$368.01M derived: sum of 3 quarters · filed 2023-02-28 | -$478.39M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$123.79M 10-Q · filed 2022-11-04 | -$242.21M derived: sum of 2 quarters · filed 2023-02-28 | -$352.59M derived: sum of 3 quarters · filed 2023-02-28 | -$425.00M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$118.42M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$228.80M derived: sum of 2 quarters · filed 2023-02-28 | -$301.21M derived: sum of 3 quarters · filed 2023-02-28 | -$445.73M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$110.38M 10-Q · filed 2021-11-05 | -$182.79M derived: sum of 2 quarters · filed 2021-11-05 | -$327.31M 10-Q · filed 2021-11-05 | -$440.57M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$72.41M 10-Q · filed 2021-11-05 | -$216.93M 10-Q · filed 2021-08-06 | -$330.19M derived: sum of 3 quarters · filed 2022-03-01 | -$429.39M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$144.52M 10-Q · filed 2021-11-05 | -$257.78M derived: sum of 2 quarters · filed 2022-03-01 | -$356.99M derived: sum of 3 quarters · filed 2022-03-01 | -$464.97M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$113.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$212.46M derived: sum of 2 quarters · filed 2022-03-01 | -$320.44M derived: sum of 3 quarters · filed 2022-03-01 | -$435.36M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$99.21M 10-Q · filed 2020-11-06 | -$207.19M derived: sum of 2 quarters · filed 2020-11-06 | -$322.10M 10-Q · filed 2020-11-06 | -$421.25M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$107.98M 10-Q · filed 2020-11-06 | -$222.89M 10-Q · filed 2020-08-07 | -$322.04M derived: sum of 3 quarters · filed 2021-02-26 | -$419.56M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$114.91M 10-Q · filed 2020-11-06 | -$214.06M derived: sum of 2 quarters · filed 2021-02-26 | -$311.58M derived: sum of 3 quarters · filed 2021-02-26 | $658.67M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$99.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$196.67M derived: sum of 2 quarters · filed 2021-02-26 | $773.59M derived: sum of 3 quarters · filed 2021-02-26 | $677.11M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$97.52M 10-Q · filed 2019-11-07 | $872.74M derived: sum of 2 quarters · filed 2019-11-07 | $776.26M 10-Q · filed 2019-11-07 | $742.23M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $970.25M 10-Q · filed 2019-08-09 | $873.78M 10-Q · filed 2019-08-09 | $839.75M derived: sum of 3 quarters · filed 2020-02-28 | $900.37M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | -$96.48M 10-Q · filed 2019-05-09 | -$130.51M derived: sum of 2 quarters · filed 2020-02-28 | -$69.88M derived: sum of 3 quarters · filed 2020-02-28 | -$129.56M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$34.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $26.60M derived: sum of 2 quarters · filed 2020-02-28 | -$33.09M derived: sum of 3 quarters · filed 2020-02-28 | -$96.44M 10-K · filed 2020-02-28 |
| 2017-09-30 | $60.63M 10-Q · filed 2018-11-08 | $942.00K derived: sum of 2 quarters · filed 2018-11-08 | -$62.41M 10-Q · filed 2018-11-08 | -$105.01M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$59.68M 10-Q · filed 2018-08-09 | -$123.04M 10-Q · filed 2018-08-09 | -$165.64M derived: sum of 3 quarters · filed 2019-03-01 | -$208.80M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$63.35M 10-Q · filed 2018-05-10 | -$105.95M derived: sum of 2 quarters · filed 2019-03-01 | -$149.12M derived: sum of 3 quarters · filed 2019-03-01 | -$197.91M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$42.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$85.77M derived: sum of 2 quarters · filed 2019-03-01 | -$134.55M derived: sum of 3 quarters · filed 2019-03-01 | -$153.72M 10-K · filed 2019-03-01 |
| 2016-09-30 | -$43.17M 10-Q · filed 2017-11-08 | -$91.95M derived: sum of 2 quarters · filed 2017-11-08 | -$111.12M 10-Q · filed 2017-11-08 | -$165.60M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | -$48.79M 10-Q · filed 2017-08-09 | -$67.95M 10-Q · filed 2017-08-09 | -$122.44M derived: sum of 3 quarters · filed 2018-03-01 | -$130.96M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | -$19.16M 10-Q · filed 2017-05-10 | -$73.65M derived: sum of 2 quarters · filed 2018-03-01 | -$82.17M derived: sum of 3 quarters · filed 2018-03-01 | -$135.05M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | -$54.49M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$63.01M derived: sum of 2 quarters · filed 2018-03-01 | -$115.89M derived: sum of 3 quarters · filed 2018-03-01 | -$81.78M 10-K · filed 2018-03-01 |
| 2015-09-30 | -$8.53M 10-Q · filed 2016-11-04 | -$61.41M derived: sum of 2 quarters · filed 2016-11-04 | -$27.29M 10-Q · filed 2016-11-04 | -$73.37M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$52.88M 10-Q · filed 2016-08-04 | -$18.77M 10-Q · filed 2016-08-04 | -$64.84M derived: sum of 3 quarters · filed 2017-03-01 | $5.47M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $34.11M 10-Q · filed 2016-05-04 | -$11.96M derived: sum of 2 quarters · filed 2017-03-01 | $58.35M derived: sum of 3 quarters · filed 2017-03-01 | $25.77M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$46.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $24.24M derived: sum of 2 quarters · filed 2017-03-01 | -$8.34M derived: sum of 3 quarters · filed 2017-03-01 | -$54.30M 10-K · filed 2017-03-01 |
| 2014-09-30 | $70.31M 10-Q · filed 2015-11-06 | $37.73M derived: sum of 2 quarters · filed 2015-11-06 | -$8.23M 10-Q · filed 2015-11-06 | -$55.38M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$32.58M 10-Q · filed 2015-08-06 | -$78.54M 10-Q · filed 2015-08-06 | -$125.69M derived: sum of 3 quarters · filed 2016-02-29 | -$142.59M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$45.96M 10-Q · filed 2015-05-01 | -$93.11M derived: sum of 2 quarters · filed 2016-02-29 | -$110.01M derived: sum of 3 quarters · filed 2016-02-29 | -$153.70M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$47.15M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$64.05M derived: sum of 2 quarters · filed 2016-02-29 | -$107.74M derived: sum of 3 quarters · filed 2016-02-29 | -$162.84M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$16.90M 10-Q · filed 2014-11-07 | -$60.59M derived: sum of 2 quarters · filed 2014-11-07 | -$115.69M 10-Q · filed 2014-11-07 | -$169.12M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | -$43.69M 10-Q · filed 2014-08-01 | -$98.79M 10-Q · filed 2014-08-01 | -$152.23M derived: sum of 3 quarters · filed 2015-02-26 | -$195.00M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | -$55.10M 10-Q · filed 2014-05-08 | -$108.54M derived: sum of 2 quarters · filed 2015-02-26 | -$151.31M derived: sum of 3 quarters · filed 2015-02-26 | -$186.17M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | -$53.44M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$96.21M derived: sum of 2 quarters · filed 2015-02-26 | -$131.07M derived: sum of 3 quarters · filed 2015-02-26 | -$171.11M 10-K · filed 2015-02-26 |
| 2012-09-30 | -$42.77M 10-Q · filed 2013-11-07 | -$77.63M derived: sum of 2 quarters · filed 2013-11-07 | -$117.67M 10-Q · filed 2013-11-07 | -$155.28M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | -$34.86M 10-Q · filed 2013-08-09 | -$74.90M 10-Q · filed 2013-08-09 | -$112.51M derived: sum of 3 quarters · filed 2014-02-27 | -$138.33M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | -$40.04M 10-Q · filed 2013-05-09 | -$77.65M derived: sum of 2 quarters · filed 2014-02-27 | -$103.47M derived: sum of 3 quarters · filed 2014-02-27 | -$139.90M derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | -$37.61M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$63.43M derived: sum of 2 quarters · filed 2014-02-27 | -$99.86M derived: sum of 3 quarters · filed 2014-02-27 | -$136.05M 10-K · filed 2014-02-27 |
| 2011-09-30 | -$25.82M 10-Q · filed 2012-11-09 | -$62.25M derived: sum of 2 quarters · filed 2012-11-09 | -$98.44M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | -$36.43M 10-Q · filed 2012-08-09 | -$72.62M 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | -$36.18M 10-Q · filed 2012-05-04 | |||
| 2010-12-31 | -$37.99M 10-K · filed 2013-03-01 | |||
| 2009-12-31 | -$102.93M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |